3Z ehf
Quotes
Share:
Subscribe:
news.cision.com
/
3Z ehf
/
3Z closes $2 million funding for preclinical development of novel ADHD and Insomnia therapeutics identified by 3Z´s zebrafish drug discovery platform.
/
DSC 0258
2 of 2
DSC 0258
Mon, Jun 20, 2022 13:38 CET
Low resolution
Medium resolution
Original resolution
Subscribe
